← The Wire
BBIONasdaq
BridgeBio Pharma, Inc.
Pharmaceutical Preparations · DE · CIK 1743881
Discovers, develops, and delivers medicines for patients with genetic diseases
red 8-K · 90d
$13.08B
Market cap
$72.01
Last close
+2.5%
1D
+4.5%
5D
3.3M
Volume
Price · last 39 sessions+4.4%
May 4L $63.88 · H $72.01Jun 29
170
Total filings
Jun 26, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 26, 20268-KCompany UpdateMay 27, 20268-KCompany UpdateMay 13, 20268-KMaterial Agreement · Agreement TerminatedMay 8, 202610-Q10-QMay 7, 20268-KResults of Operations · Company UpdateMay 7, 2026DEFA14ADEFA14AApr 24, 2026DEF 14ADEF 14AApr 24, 2026SC 13D/ASC 13D/AApr 2, 20268-KCompany UpdateMar 30, 202610-K10-KFeb 24, 20268-KResults of OperationsFeb 24, 2026SC 13D/ASC 13D/AFeb 17, 20268-KCompany UpdateFeb 12, 20268-KMaterial Agreement · New Debt / ObligationJan 21, 20268-KResults of Operations · Reg FD DisclosureJan 12, 202610-Q10-QOct 29, 20258-KCompany UpdateOct 29, 20258-KResults of OperationsOct 29, 20258-KCompany UpdateOct 27, 202510-Q10-QAug 5, 20258-KResults of OperationsAug 5, 20258-KMaterial Agreement · New Debt / ObligationJul 2, 20258-KSecurity-Holder Rights · Bylaw AmendmentJun 23, 2025DEFA14ADEFA14AMay 9, 2025DEFA14ADEFA14AApr 30, 2025DEF 14ADEF 14AApr 30, 202510-Q10-QApr 29, 20258-KResults of OperationsApr 29, 20258-KExecutive Change · Reg FD DisclosureMar 17, 20258-KMaterial Agreement · Agreement TerminatedFeb 28, 202510-K10-KFeb 20, 20258-KResults of OperationsFeb 20, 20258-KResults of Operations · Reg FD DisclosureJan 13, 20258-KCompany UpdateNov 25, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 20248-KCompany UpdateSep 11, 20248-KMaterial AgreementAug 21, 202410-Q10-QAug 1, 20248-KResults of OperationsAug 1, 20248-KExecutive Change · Reg FD DisclosureJul 23, 20248-KShareholder VoteJun 24, 20248-KCompany UpdateJun 6, 202410-Q10-QMay 2, 20248-KResults of OperationsMay 2, 2024DEFA14ADEFA14AApr 25, 2024DEF 14ADEF 14AApr 25, 2024424B5424B5Mar 6, 20248-KMaterial Agreement · Company UpdateMar 6, 2024424B5424B5Mar 4, 20248-KMaterial AgreementMar 4, 202410-K10-KFeb 22, 20248-KResults of OperationsFeb 22, 20248-KMaterial Agreement · Agreement TerminatedJan 18, 20248-KCompany UpdateJan 8, 202410-Q10-QNov 2, 20238-KResults of OperationsNov 2, 20238-KMaterial Agreement · Equity IssuanceSep 25, 202310-Q10-QAug 3, 20238-KResults of OperationsAug 3, 20238-KReg FD Disclosure · Company UpdateJul 17, 20238-KShareholder VoteJun 22, 20238-KMaterial Agreement · Agreement TerminatedMay 4, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KMaterial Agreement · Company UpdateMar 9, 2023424B5424B5Mar 9, 2023424B5424B5Mar 6, 20238-KReg FD Disclosure · Company UpdateMar 6, 202310-K10-KFeb 23, 20238-KExecutive Change · Results of OperationsFeb 23, 2023SC 13GSC 13GFeb 8, 20238-KMaterial Agreement · New Debt / ObligationDec 6, 20228-KResults of Operations · Company UpdateNov 3, 202210-Q10-QNov 3, 20228-KCompany UpdateSep 23, 202210-Q10-QAug 4, 2022
Insider Activity
In the 90 days to Mar 13, 2026: 6 sold $30.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 13, 2026 | Kumar NeilChief Executive Officer | Sell | 10,310 | $69.20 | $713K |
| Mar 13, 2026 | Kumar NeilChief Executive Officer | Sell | 10,241 | $68.39 | $700K |
| Mar 13, 2026 | Kumar NeilChief Executive Officer | Sell | 9,759 | $69.23 | $676K |
| Mar 13, 2026 | Kumar NeilChief Executive Officer | Sell | 9,690 | $68.36 | $662K |
| Mar 12, 2026 | Kumar NeilChief Executive Officer | Sell | 14,337 | $68.48 | $982K |
| Mar 12, 2026 | Kumar NeilChief Executive Officer | Sell | 13,885 | $68.47 | $951K |
| Mar 12, 2026 | Kumar NeilChief Executive Officer | Sell | 5,815 | $69.29 | $403K |
| Mar 12, 2026 | Kumar NeilChief Executive Officer | Sell | 5,363 | $69.32 | $372K |
| Mar 12, 2026 | Kumar NeilChief Executive Officer | Sell | 300 | $70.15 | $21K |
| Mar 10, 2026 | Valantine HannahDirector | Sell | 8,671 | $72.00 | $624K |
| Mar 4, 2026 | Ellis AndreaDirector | Sell | 64,921 | $64.87 | $4.2M |
| Feb 27, 2026 | Valantine HannahDirector | Sell | 14,584 | $67.08 | $978K |
| Feb 27, 2026 | Valantine HannahDirector | Sell | 10,900 | $67.84 | $739K |
| Feb 26, 2026 | Apuli MaricelChief Accounting Officer | Sell | 2,000 | $66.00 | $132K |
| Feb 19, 2026 | Kumar NeilChief Executive Officer | Sell | 18,923 | $71.03 | $1.3M |
| Feb 19, 2026 | Kumar NeilChief Executive Officer | Sell | 8,528 | $72.08 | $615K |
| Feb 19, 2026 | Kumar NeilChief Executive Officer | Sell | 602 | $72.80 | $44K |
| Feb 17, 2026 | Trimarchi ThomasPresident and CFO | Sell | 13,400 | $74.71 | $1.0M |
| Feb 17, 2026 | Scott Randal W.Director | Sell | 4,793 | $75.57 | $362K |
| Feb 17, 2026 | Scott Randal W.Director | Sell | 3,307 | $75.93 | $251K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance